Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution

被引:7
|
作者
Li, Dateng [1 ]
Zhang, Song [2 ]
Cao, Jing [1 ]
机构
[1] Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci, Dallas, TX 75390 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
correlated count measurements; negative binomial distribution; overdispersion; sample size; REGRESSION; POISSON; MODELS;
D O I
10.1002/sim.8378
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Statistical inference based on correlated count measurements are frequently performed in biomedical studies. Most of existing sample size calculation methods for count outcomes are developed under the Poisson model. Deviation from the Poisson assumption (equality of mean and variance) has been widely documented in practice, which indicates urgent needs of sample size methods with more realistic assumptions to ensure valid experimental design. In this study, we investigate sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution. This approach is flexible to accommodate overdispersion and unequal measurement intervals, as well as arbitrary randomization ratios, missing data patterns, and correlation structures. Importantly, the derived sample size formulas have closed forms both for the comparison of slopes and for the comparison of time-averaged responses, which greatly reduces the burden of implementation in practice. We conducted extensive simulation to demonstrate that the proposed method maintains the nominal levels of power and type I error over a wide range of design configurations. We illustrate the application of this approach using a real epileptic trial.
引用
收藏
页码:5413 / 5427
页数:15
相关论文
共 50 条
  • [32] On sample size calculation in bioequivalence trials
    Chow, SC
    Wang, HS
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2001, 28 (02) : 155 - 169
  • [33] On Sample Size Calculation in Bioequivalence Trials
    Shein-Chung Chow
    Hansheng Wang
    Journal of Pharmacokinetics and Pharmacodynamics, 2001, 28 : 155 - 169
  • [34] Reducing sample size in negative binomial UMPU test
    Bandyopadhyay, Uttam
    Mukherjee, Shirsendu
    Dutta, Dhiman
    STATISTICS & PROBABILITY LETTERS, 2015, 103 : 57 - 61
  • [35] Sample Size Calculation When Planning Clinical Trials with Intercurrent Events
    Yixin Fang
    Man Jin
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 779 - 785
  • [36] Sample Size Calculation When Planning Clinical Trials with Intercurrent Events
    Fang, Yixin
    Jin, Man
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (04) : 779 - 785
  • [37] Sample size calculation for the augmented logrank test in randomized clinical trials
    Hattori, Satoshi
    Komukai, Sho
    Friede, Tim
    STATISTICS IN MEDICINE, 2022, 41 (14) : 2627 - 2644
  • [38] THE QUALITY OF SAMPLE SIZE CALCULATION (SSC) REPORTING IN CANCER CLINICAL TRIALS
    Bariani, G. M.
    Ferrari, A. C. R. C.
    Hoff, P. M.
    Arai, R.
    Precivale, M.
    Riechelmann, R. P.
    ANNALS OF ONCOLOGY, 2012, 23 : 450 - 450
  • [39] Analysis of frequency count data using the negative binomial distribution
    White, GC
    Bennetts, RE
    ECOLOGY, 1996, 77 (08) : 2549 - 2557
  • [40] Sequence count data are poorly fit by the negative binomial distribution
    Hawinkel, Stijn
    Rayner, J. C. W.
    Bijnens, Luc
    Thas, Olivier
    PLOS ONE, 2020, 15 (04):